• Parasitic worms offer 'the missing link'

    From ScienceDaily@1337:3/111 to All on Fri Nov 13 21:30:30 2020
    Parasitic worms offer 'the missing link' on the dual nature of a key
    immune regulator

    Date:
    November 13, 2020
    Source:
    University of Pennsylvania
    Summary:
    By studying two models of parasite infection, researchers filled
    in crucial gaps about the activity of the signaling molecule IL-33
    that is critical to asthma, allergies, and other diseases.



    FULL STORY ========================================================================== De'Broski Herbert has a philosophy that's guided his career researching helminths, or parasitic worms, and their interaction with their hosts'
    immune systems: "Follow the worm."

    ==========================================================================
    "The mantra of my lab since its inception has been that parasitic
    worms manipulate their hosts in very interesting ways to maintain their survival," says Herbert, an associate professor of pathobiology in Penn's School of Veterinary Medicine. "SARS-CoV-2 doesn't care about staying
    in your body very long because it is transmitted so easily. Worms
    aren't spread so easily, so they have to figure out how to persist."
    That focus has revealed a key insight about an immune signaling molecule,
    the cytokine IL-33, that is important not only in parasite infections,
    but in a range of other health conditions, such as asthma, obesity,
    and eczema. In a new study published in Science Immunology, Herbert and colleagues made insights that explain how IL-33 can both help defend the
    body against parasite infection, but also suppress chronic inflammation
    in diseases where the immune system is activated inappropriately and
    causes harmful pathology. A key discovery was that the activity of IL-33 depends upon which cell type is releasing it.

    "Lots of people have been interested in IL-33 ever since two big genomic association studies implicated it and its receptor in the pathogenesis of asthma," Herbert says. "Other researchers have looked at it in the context
    of infections and others in the context of the brain and development. And everyone knew this protein was in the nucleus, but no one understood
    how it got out of the cell to accomplish all of these things.

    "I'm excited for this work because not only do we find this cytokine in
    a cell type that nobody was expecting, but we also present a mechanism
    that no one was expecting for how it could come out." IL-33 has been
    of major interest to immunologists focused on what are known as type
    2 immune responses, typically associated with parasite infections or
    asthma and allergies. On the parasite front, researchers knew that
    IL-33 acted in part to "wake up" the immune system to the presence of
    a worm infection. In a mouse model, animals lacking IL-33 sustain worm infections much longer than those with IL-33 intact.



    ==========================================================================
    To find out whether it mattered which cell type was releasing the IL-33 signaling molecule, Herbert and colleagues used special mouse model in
    which only myeloid antigen-presenting cells (immune cells), or epithelial
    cells (those that line mucosal surfaces), failed to release IL-33.

    "Sure enough, we found that when animals lacking the myeloid-derived
    IL-33 experienced a hookworm infection, they eliminated those hookworms
    quite fast," Herbert says. Mice lacking IL-33 in the epithelial cells,
    however, were not able to readily clear the infection. The same results
    held up in another rodent model, this one of roundworm infection.

    Dendritic cells, a type of myeloid antigen-presenting cell, produce IL-33,
    and further experiments showed that the cytokine produced by these cells supported a specific population of regulatory T cells (Tregs), which
    are cells "whose whole purpose is to suppress the immune response,"
    Herbert says.

    Now understanding that dendritic cells were key to supporting Tregs, the researchers wanted to understand how the dendritic cells were delivering
    the IL-33. The team screened dendritic cells from mice with and without
    IL-33, identifying a protein called perforin-2 to be suppressed in
    expression from myeloid cells lacking IL-33.

    Perforin-2, as its name suggests, forms a pore that spans the cell
    membrane, like a tunnel in a hillside, allowing the transport of proteins
    in and out. The find made complete sense to the researchers, providing
    an explanation for how dendritic cells could promote the release of
    IL-33 into the tissues to interact with Tregs. And when Herbert and
    colleagues experimentally eliminated perforin- 2 from dendritic cells,
    they saw a subsequent lack of Treg growth.

    To connect the findings in their animal model and lab dishes to humans,
    the team utilized patient samples from Penn otolaryngologist Noam
    Cohen. They found perforin-2 at the plasma membrane of cells from polyps removed from patients with chronic rhinosinusitis, suggesting that the significance of the findings extends to human health.

    The study paves the way for even more translational work in immunology --
    and worms are to thank. "It's kind of the missing link," Herbert says. "It opens up a whole new direction for understanding how this cytokine could
    be involved in obesty, inflammatory bowel disease, Crohn's, asthma,
    and development."

    ========================================================================== Story Source: Materials provided by University_of_Pennsylvania. Note:
    Content may be edited for style and length.


    ========================================================================== Journal Reference:
    1. Li-Yin Hung, Yukinori Tanaka, Karl Herbine, Christopher Pastore,
    Brenal
    Singh, Annabel Ferguson, Nisha Vora, Bonnie Douglas, Kelly Zullo,
    Edward M. Behrens, Tiffany Li Hui Tan, Michael A. Kohanski,
    Paul Bryce, Cailu Lin, Taku Kambayashi, Danielle R. Reed, Breann
    L. Brown, Noam A. Cohen, and De'broski R. Herbert. Cellular
    context of IL-33 expression dictates impact on anti-helminth
    immunity. Science Immunology, 2020 DOI: 10.1126/ sciimmunol.abc6259 ==========================================================================

    Link to news story: https://www.sciencedaily.com/releases/2020/11/201113154620.htm

    --- up 11 weeks, 4 days, 7 hours, 50 minutes
    * Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1337:3/111)